Literature DB >> 7561977

MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry.

P R Gerber1, K Müller.   

Abstract

The mathematical formulation, parametrization scheme, and structural results of a new, generally applicable molecular force field are presented. The central features are a scheme for automatic parameter assignments, the consistent united-atom approximation, the absence of atom types other than elements, the replacement of electrostatic terms by geometrical hydrogen-bonding terms, the concomitant lack of a need for partial atomic charge assignment and the strict adherence to a finite-range design. As a consequence of omitting all hydrogen atoms, optimal hydrogen-bond patterns are computed dynamically by appropriate network analyses. For a test set of 1589 structures, selected from the Cambridge Structural Database solely on the grounds of a given element list and criteria for high structure refinement, the agreements are on average 2 pm for bonds, 2 degrees for valence angles and 10 to 20 pm for the root-mean-square deviation of atom positions, depending somewhat on size and flexibility of the structures. More qualitative testing of large-scale structural properties of the force field on proteins and DNA oligomers revealed satisfactory performance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561977     DOI: 10.1007/BF00124456

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  3 in total

1.  Derivation of force fields for molecular mechanics and dynamics from ab initio energy surfaces.

Authors:  J R Maple; U Dinur; A T Hagler
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Reversible bending and helix geometry in a B-DNA dodecamer: CGCGAATTBrCGCG.

Authors:  A V Fratini; M L Kopka; H R Drew; R E Dickerson
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

3.  Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim.

Authors:  D A Matthews; J T Bolin; J M Burridge; D J Filman; K W Volz; B T Kaufman; C R Beddell; J N Champness; D K Stammers; J Kraut
Journal:  J Biol Chem       Date:  1985-01-10       Impact factor: 5.157

  3 in total
  123 in total

1.  Methodological developments and strategies for a fast flexible superposition of drug-size molecules.

Authors:  G Klebe; T Mietzner; F Weber
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

2.  De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks.

Authors:  G Schneider; M L Lee; M Stahl; P Schneider
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

3.  Evaluation of designed ligands by a multiple screening method: application to glycogen phosphorylase inhibitors constructed with a variety of approaches.

Authors:  S S So; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

4.  Optimization of the catalytic properties of Aspergillus fumigatus phytase based on the three-dimensional structure.

Authors:  A Tomschy; M Tessier; M Wyss; R Brugger; C Broger; L Schnoebelen; A P van Loon; L Pasamontes
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

5.  Exploring amyloid formation by a de novo design.

Authors:  Richard A Kammerer; Dirk Kostrewa; Jesús Zurdo; Andreas Detken; Carlos García-Echeverría; Janelle D Green; Shirley A Müller; Beat H Meier; Fritz K Winkler; Christopher M Dobson; Michel O Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

6.  Here be dragons: docking and screening in an uncharted region of chemical space.

Authors:  Ruth Brenk; John J Irwin; Brian K Shoichet
Journal:  J Biomol Screen       Date:  2005-09-16

7.  Structural basis for conductance by the archaeal aquaporin AqpM at 1.68 A.

Authors:  John K Lee; David Kozono; Jonathan Remis; Yoshichika Kitagawa; Peter Agre; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-16       Impact factor: 11.205

8.  Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.

Authors:  Stefania Morandi; Federica Morandi; Emilia Caselli; Brian K Shoichet; Fabio Prati
Journal:  Bioorg Med Chem       Date:  2007-11-07       Impact factor: 3.641

9.  Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa.

Authors:  Connor J Cooper; Ganesh Krishnamoorthy; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerry M Parks; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2018-05-25       Impact factor: 5.084

10.  Cyanoacetamide MCR (III): three-component Gewald reactions revisited.

Authors:  Kan Wang; Dabin Kim; Alexander Dömling
Journal:  J Comb Chem       Date:  2010 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.